The cumulative risk of non-Hodgkin lymphoma (NHL) in Sweden by age 80 years has increased to 1.1 in women and 1.6% in men in 2011. Increased risk of NHL associated with personal histories of some autoimmune diseases (ADs) is known. It is unclear whether there are other NHL-related ADs and whether this association holds across different sex, age and year of diagnosis, or NHL histological subtypes. Results: Of 33 studied ADs, 21 showed significantly increased risk of NHL; 6 of them tended to increase the risk and none significantly decreased it. The overall standardized incidence ratio (SIR) for NHL after ADs was 1.6 [novel findings: immune thrombocytopenic purpura (ITP) = 7.5, polymyositis/dermatomyositis = 4.1, primary biliary cirrhosis = 3.9, myasthenia gravis = 2.2, Behcet = 1.7, rheumatoid fever = 1.7, ulcerative colitis = 1.5, polymyalgia rheumatica = 1.4, and chronic rheumatic heart disease = 1.4; confirmatory findings: autoimmune hemolytic anemia = 27.2, Sjögren = 4.9, Celiac = 4.8, systemic lupus erythematosus = 4.4, polyarteritis nodosa = 2.9, discoid lupus erythematosus = 2.7, sarcoidosis = 2.6, Crohn = 2.1, systemic sclerosis = 2.1, rheumatoid arthritis = 2.0, and Hashimoto/hypothyroidism and psoriasis = 1.4]. SIR for NHL diagnosis before age 60 (2.2) was significantly higher than that in older ages (age ≥60: 1.5). The SIRs in women or men and in period 1993-2010 or 1964-1992 were similar. Risk of all common NHL histology subtypes significantly increased after ADs (cutaneous/peripheral T cell and anaplastic large T and null cell = 2.2; small B-cell lymphocytic = 1.7; diffuse large B cell = 1.6; follicular and mantel cell = 1.3).
about three fourths of the patients with ADs are women suggesting that sex differences affect the incidence of AD although the sex ratio varies depending on the disease [23] . The more frequent the AD and the later it appears, the more women are affected [24] . The AD and NHL diagnostics and treatments have changed over the years with improvements in survival. Based on current knowledge on this subject, we hypothesized that potentially all ADs could be associated with increased risk of NHL and the reasons that previous studies did not find some of them could be exclusion of some ADs from the study, small sample size, or case-control design, which is prone to various biases. We thus aimed for the first time to comprehensively investigate whether other ADs are related to NHL in a very large-scale cohort study, and also to ascertain if the association of NHL and ADs differs by histological subtype of NHL, sex, and age and for the first time period at diagnosis of cancer covering the total Swedish population from1964 to 2010.
materials and methods
The study population has been described elsewhere [1] . In brief, AD patients were identified from all Swedish health care databases, which contain data on all hospital discharges (dates of hospitalization and diagnoses), Outpatient Registry, and Primary Health Care Registry in Stockholm and Region Skåne (for some regions of Sweden since 1964 and for the whole Sweden since 1986). By means of the individual national identification number, linkages of these registries, the Swedish Cancer Registry (1.7 million recorded primary cancer patients out of 14.7 million people), causespecific death register and national census data were carried out. The study protocol was approved by the regional Ethics Committee at the Lund University.
A total of 33 ADs were covered (supplementary Table S1 , available at Annals of Oncology online). The International Classification of Diseases codes used have been described previously [1, 25, 26] . However, there were less than three cases of NHL after two ADs [chorea minor (n = 0) and lupoid hepatitis (n = 2)]. These diseases were not significantly associated with NHL (as assessed by standardized incidence ratio; SIR) and SIR data are not shown for them, although they contributed in the estimates for 'All' ADs (last row of each table) .
SIR calculations and more explanations about the method used in this study are presented in the supplementary Material, available at Annals of Oncology online.
results
Baseline characteristics of >878 000 AD patients diagnosed 1964-2010 are shown in Table 1 . Although amyotrophic lateral sclerosis, and ankylosing spondylitis, Behcet disease, diabetes mellitus type I, Reiter disease, and rheumatic fever were male predominant, women constituted ∼60% of all AD patients. About 59% of AD patients were diagnosed at age 50 years or older although celiac, Crohn and Reiter diseases, ankylosing spondylitis, and ulcerative colitis were mostly (>60%) diagnosed in youth. Of the 33 ADs that we analyzed, 31 had at least three cases of NHLs and these are shown in the remaining tables.
Of 33 studied ADs, 21 showed significantly increased risk of NHL; 6 of them tended to increase the risk and none significantly decreased it. The overall SIR for NHL after ADs was significantly increased to 1.6 (last row in Table 1 ). SIRs were significantly increased after autoimmune hemolytic anemia 27.2, immune thrombocytopenic purpura (ITP) 7.5, Sjögren syndrome 4.9, Celiac disease 4.8, SLE 4.4, polymyositis/dermatomyositis 4.1, primary biliary cirrhosis 3.9, polyarteritis nodosa 2.9, DLE 2.7, sarcoidosis 2.6, Crohn disease and myasthenia gravis 2.2, systemic sclerosis 2.1, RA 2.0, Behcet disease and rheumatoid fever 1.7, ulcerative colitis 1.5, polymyalgia rheumatica, Hashimoto/hypothyroidism, and psoriasis and chronic rheumatic heart disease 1.4). In the database, we had variables for history of hospitalization for obesity and chronic obstructive pulmonary diseases (as proxy to heavy smoking). The results after further adjustment for these risk factors did not substantially change.
sex and age at diagnosis of NHL The overall SIR of NHL after ADs was similar in men (1.7) and women (1.6; Table 1 ). The AD-specific SIRs also did not show any significant sex differences. The data were also analyzed according to the age at diagnosis of NHL (Table 2 and supplementary Table S2 , available at Annals of Oncology online). Most of NHL patients had been diagnosed at older ages (age ≥60) in line with age distribution of NHL. However, in general, increased risk of NHL for those diagnosed before age 60 years (overall SIR 2.2) was significantly higher than that in those diagnosed at older ages (age ≥60: 1.5), although this pattern was reverse for ITP, so that the SIR was highest in older age at NHL diagnosis [age <60: 5.9; age ≥60: 7.9; 95% confidence interval (CI) overlapped].
period at diagnosis of NHL and AD
The overall SIR was similarly increased when ADs and NHLs had been diagnosed either in period 1964-1992 (1.9; supplementary Table S2 , available at Annals of Oncology online) or in 1993-2010 (1.7). A significantly difference in SIRs between periods was noted only for celiac disease (11.7 in earlier period versus 4.4 in recent period) and psoriasis (2.1 versus 1.3).
histological subtype of NHL Supplementary Table S3 , available at Annals of Oncology online, shows that, in general, risk of most common NHL subtypes was increased after ADs (cutaneous/peripheral T cell and anaplastic large T and null cell 2.2; small B-cell lymphocytic 1.7; diffuse large B cell 1.6; follicular and mantel cell 1.3). When there was a decent sample size in the AD-specific analyses (e.g. at least five cases for each histology), our results showed that ADs do not exclusively associate with a particular histological subtype of NHL, although a tendency toward higher SIRs for cutaneous/peripheral T-cell and anaplastic large T-and null cell subtypes was notable. For instance, celiac disease markedly increased risk of cutaneous/peripheral T-cell (15.9) and anaplastic large T-and null cell NHLs (13.2). Among other NHL subtypes, risk of Burkitt lymphoma tended to increase modestly (1.4, 95% CI 0.8-2.2, n = 15; data not shown), which was mainly conformed to its risk after Sjögren syndrome (13.3, 95% CI 1.3-48.8, n = 2) and sarcoidosis (5.9, 95% CI 0.6-21.6, n = 2). Risk of lymphoblastic lymphoma also tended to modestly increase (1.5, 95% CI 0.7-2.85, n = 9; data not shown), especially after DLE and ITP. 
discussion
The present cohort study, benefiting from a nationwide database with a long-term follow-up (up to 47 years), for the first time showed a significant association of risk of NHL with several ADs such as ITP (SIR = 7.5), polymyositis/dermatomyositis 4.1, primary biliary cirrhosis 3.9, myasthenia gravis 2.2, Behcet disease 1.7, rheumatoid fever 1.7, ulcerative colitis 1.5, polymyalgia rheumatica 1.4, and chronic rheumatic heart disease 1.4. This cohort study also confirmed the association of some already known NHL-related ADs (hemolytic anemia 27.2, Sjögren syndrome 4.9, celiac disease 4.8, SLE 4.4, polyarteritis nodosa 2.9, DLE 2.7, sarcoidosis 2.6, Crohn disease 2.2, systemic sclerosis 2.1, RA 2.0, and psoriasis 1.4), which had [10, 11] . Only about onefifth of our AD and NHL patients were overlapped with the previous Scandinavian study, but the current study with a cohort design had more power, especially for stratified analyses by sex, age, period, and histology. The histology-specific analysis showed no significant differences among ADs exclusively toward a specific histological subtype of NHL, although a tendency toward higher risk of cutaneous/peripheral T-cell and anaplastic large T-and null cell subtypes was notable. Our finding may suggest that the role of predisposing immune-related factors in the differentiation of histological subtypes of NHL after ADs is not as strong as its role in the development of NHL as such.
Our age-specific analyses revealed a decreasing trend for overall risk of NHL after AD by increasing age (except for ITP), although the magnitude of decrease was not dramatic (2.2-1.5). As the incidence of NHL continuously increases by age and our study subjects were patients with a precondition of AD (which mostly affect elderly people), normally the cases of NHL should have been those toward elderly patients.
Although some of the patients were diagnosed with AD or NHL several decades ago and historic diagnosis of either could be inaccurate, the similarly increased risk of NHL after AD in two different periods (<1993 and ≥1993) may rule out any biased finding in this regard. This may indicate that although absolute risk of NHL in the background population has increased by time, the relative risks (SIRs) provided in this study are still valid. In fact, it is recommended that relative risks are used along with the latest background population risk because the absolute risk from this study could have been underestimated as it was the average risk during last five decades. That is why absolute risks are not explicitly provided. For example relative risk of NHL after ITP was 7.4 in men, given background absolute NHL lifetime risk of 1.6% in men, the lifetime risk of NHL in those with ITP would be 11.8% (7.4 × 1.6) in men (women: 8.4%). In terms of absolute risk, overall impact of many ADs, e.g. those with SIR <2, on increased risk of NHL could not be considered as very large.
Most of histological subtypes of NHL (diffuse large B-cell, follicular, mantle cell, marginal zone, plasmablastic, small lymphocytic, and Burkitt lymphomas) and many autoantibody producing ADs have a common B-cell origin [27] . However, our finding for associations of ADs and NHL were not limited to Most of NHLs and many ADs share B cell as the common cell lineage origin. Disruption of the delicate balance between activating and inhibitory signals that regulate normal B-cell activation and longevity can predispose to pathogenic autoantibody production and autoimmunity [27] . Goldin and Landgren have suggested that autoimmunity may lead to both overstimulation and defective apoptosis of B cells [14] . Other possible mechanisms involved in autoimmunity and lymphomagenesis could be secondary inflammation due to autoimmune stimulation, cytokine and chemokine release, several infections including human immunodeficiency virus, hepatitis C, and EpsteinBarr virus, and genetic factors (germline and somatic mutations) predisposing to both ADs and lymphomas may also play a substantial role [14, 28] . NHL and ADs are influenced by genetic variation in the major histocompatibility complex [9] . Human leukocyte antigen region, especially class II, has the association with lymphoma risk and celiac disease [29] . While epigenetic mechanisms may play a major role in dysregulation of Thelper 17 (Th17) or T-regulatory (Tregs) cell homeostasis, Tregs and Th17 imbalance contributes to both autoimmunity and hematologic malignancies [30] . Hansen et al. have suggested the mechanisms by which specific dysregulation and hyperactivity of B cells associated with ADs and impaired T-cell function may lead to lymphomagenesis [31] . Whether there is one main underlying mechanism for several of these conditions in relation to NHL risk or are the associations due to several possible mechanisms is unknown.
In conclusion, many of 33 studied ADs (except for ankylosing spondylitis, diabetes type I graves/hyperthyroidism, multiple sclerosis, chorea minor, and pernicious anemia), especially when diagnosed at younger ages, were associated with higher risk of NHL, particularly cutaneous/peripheral T-cell and anaplastic large T-and null cell lymphomas. However, the absolute risk on NHL in many ADs is still small. Increased risk of NHL after ITP, polymyositis/dermatomyositis, primary biliary cirrhosis, myasthenia gravis, Behcet disease, rheumatoid fever, ulcerative colitis, polymyalgia rheumatica, and chronic rheumatic heart disease was novel finding of this study. The weak associations found for most of the ADs make it difficult to use these AD patients for studying pathogenesis. 
